Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Accessory Inspiratory Muscles in Chronic Neck Pain

NCT07782099 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-06-10
Last updated
2026-08-24

Condition(s) studied

Chronic Neck PainHealthy (Controls)

Investigational drug(s) / intervention(s)

Diaphragm UltrasonographyAnterior Scalene Muscle UltrasonographyUpper Trapezius Muscle UltrasonographyMaximal Inspiratory Pressure MeasurementMaximal Expiratory Pressure MeasurementPulmonary Function Testing

Diaphragm Ultrasonography: Diaphragm thickness was assessed by ultrasonography while the participant was in a standardized position. Measurements were obtained at the end of expiration and during maximal inspiration.

Anterior Scalene Muscle Ultrasonography: Anterior scalene muscle thickness was assessed by ultrasonography while the participant was in a standardized position. Measurements were obtained at rest and during maximal inspiratory effort.

Upper Trapezius Muscle Ultrasonography: Upper trapezius muscle thickness was assessed by ultrasonography while the participant was in a standardized position. Measurements were obtained at rest and during maximal inspiratory effort.

Maximal Inspiratory Pressure Measurement: Maximal inspiratory pressure was measured using a respiratory pressure measurement device. The participant performed a maximal inspiratory effort against an occluded airway after complete expiration. Repeated measurements were performed with appropriate rest intervals.

Maximal Expiratory Pressure Measurement: Maximal expiratory pressure was measured using a respiratory pressure measurement device. The participant performed a maximal expiratory effort against an occluded airway after maximal inspiration. Repeated measurements were performed with appropriate rest intervals.

Pulmonary Function Testing: Pulmonary function testing was performed using spirometry while the participant was in a standardized seated position. The participant completed maximal forced expiratory maneuvers following standardized instructions, and technically acceptable measurements were recorded.

Study summary

This cross-sectional case-control study aims to investigate the ultrasonographic structural and functional characteristics of accessory inspiratory muscles in individuals with chronic non-specific neck pain and compare them with healthy controls. In addition, the relationships between accessory inspiratory muscle characteristics, diaphragm function, respiratory muscle strength, and pulmonary function parameters will be examined. The findings may improve understanding of the respiratory involvement associated with chronic neck pain and contribute to more comprehensive assessment strategies.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria Chronic Non-Specific Neck Pain Group: * Age between 18 and 65 years * Presence of chronic non-specific neck pain for at least 3 months * Non-traumatic origin of neck pain * Pain intensity ≥ 3 on the Numeric Pain Rating Scale (NPRS) or Visual Analog Scale (VAS) * Neck Disability Index (NDI) score ≥ 15 * Willingness to participate and provide informed consent Healthy Control Group: * Age between 18 and 65 years * No neck pain during the previous 3 months * Not receiving any treatment related to the cervical region * Willingness to participate and provide informed consent Exclusion Criteria (Both Groups): * History of whiplash injury or cervical trauma * Previous cervical spine surgery * Cervical radiculopathy or neurological deficits * Chronic respiratory diseases (e.g., COPD, asthma) * Active respiratory tract infection * Thoracic or abdominal surgery within the previous 6 months * Rheumatologic, neuromuscular, or systemic inflammatory disorders * Pregnancy * Physiotherapy treatment for neck pain within the previous 3 months * Regular respiratory muscle training or breathing exercises within the previous 3 months * Inability to comply with study procedures or assessments

Primary outcome measure(s)

  • Diaphragm Thickening Ratio — Baseline
    Diaphragm thickening ratio measured using ultrasonography.
  • Sternocleidomastoid Muscle Thickness — Baseline
    Sternocleidomastoid muscle thickness measured using ultrasonography.

Trial sites (1)

FacilityCityRegionStatus
Derince Training and Research Hospital Kocaeli Derince Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07782099 on ClinicalTrials.gov ↗ ← All trials in Turkey